Facing Crisis, Sloan Kettering Tells Exec to Hand Over Profits From Biotech
Memorial Sloan Kettering Cancer Center tells VP Gregory Raskin, MD to turn over $1.4 million worth of biotech company shares that he personally owns, and promises to revise its commercialization and investment policies so that it will retain any proceeds accruing from the involvement of its executives instead of enriching those execs.
Diagnosing the Orion Health buyout deal: Q&A
Orion Health shareholders approve the company’s plan to sell its only profitable division, which offers the Rhapsody integration engine, to a private equity firm that will run it as a private company.
Health care payments firm wants to merge with Athenahealth
Revenue cycle technology vendor NThrive (the former MedAssets and Precyse) is the previously unnamed strategic bidder that has offered to buy Athenahealth.
SingHealth COI hearing: Former IHiS CEO dismissed staff for ethical breach, didn’t probe alleged vulnerability
The former CEO of SingHealth’s IT services organization IHIS, testifying in hearings about its recent massive IT breach, says she immediately fired an employee who in 2014 discovered a security vulnerability in Allscripts Sunrise Clinical Manager and then emailed Epic to suggest using his information to increase market share.